| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 06/28/2006 | EP1674096A2 Hypoglycemics comprising organic zinc (II) complexes |
| 06/28/2006 | EP1673357A2 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain |
| 06/28/2006 | EP1673356A1 Substituted benzylaminoalkylene heterocycles |
| 06/28/2006 | EP1673350A2 Method for producing acyl urea derivatives, salts of said acyl urea derivatives, and the use thereof as pesticides |
| 06/28/2006 | EP1673342A2 Amides that inhibit vanilloid receprot subtype 1 (vr1) receptor |
| 06/28/2006 | EP1673090A1 Fused-aryl and heteroaryl derivatives and methods of their use |
| 06/28/2006 | EP1673088A1 1,1,1- trifluoro-4-phenyl-4-methyl-2-(1h-pyrrolo¬2,3-c|pyridin-2-ylmethyl)pentan-2-ol derivatives and related compounds as glucocorticoid ligands for the treatment of inflammatory diseases and diabetes |
| 06/28/2006 | EP1673084A1 1-2' (1,4'-biperidin-1'-yl)-1-(phenyl)-ethylcyclohexanol derivatives as monoamine reuptake modulators for the treatment of vasomotor symptoms |
| 06/28/2006 | EP1673078A2 Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease |
| 06/28/2006 | EP1673059A2 Alkanol and cycloalkanol-amine derivatives and methods of their use |
| 06/28/2006 | EP1377591B1 Tumour inhibiting gallium compounds |
| 06/28/2006 | EP1373552A4 Novel agents for replacement of nad+/nadh system in enzymatic ractions |
| 06/28/2006 | EP1254159B9 Process for the preparation of acetyl-amidiniophenylalanyl-cyclohexylglycyl-pyridylalaninamides |
| 06/28/2006 | CN1794989A N-(((((1,3-thiazol-2-yl)amino)carbonyl)phenyl)sulfonyl)phenylalanine derivatives and related compounds for the treatment of diabetes |
| 06/28/2006 | CN1794987A Nitrooxyderivatives of fluvastatin, pravastatin, cerivastatin, atorvastatin and rosuvastatin as cholesterol-reducing agents with improved anti-inflammatory, antithrombotic and antiplatelet activity |
| 06/28/2006 | CN1793150A Diene silicoxyane linking disbenzocyclobutylene monomer and process for preparing prepolymer |
| 06/28/2006 | CN1793127A Molecular rectifying material containing mercapto and preparation process thereof |
| 06/28/2006 | CN1261414C Pyridineamido derivatives as inhibitors of monoamine oxidase (MAO-B) |
| 06/28/2006 | CN1261413C Purification process for nitrogen sulfapyridine |
| 06/27/2006 | US7067681 Nitration of tetracyclines and derivatives, then reducing, diazotizing and alkylation on the presence of palladium chloride; catalysis; antibiotics |
| 06/27/2006 | US7067673 Using titanium oxide composite catalyst on supports |
| 06/27/2006 | US7067671 Useful in treatment of a variety of cytokine related disorders including rheumatoid arthritis, inflammatory bowel disease, septic shock, osteoporosis, osteoarthritis, neuropathic pain, HIV replication, HIV dementia |
| 06/27/2006 | US7067665 phenylethoxy-phenyl- or -pyridyl- (acet) amides, N-substituted with pyrimidine ring-containing (tetrahydro)pyridines or phenyl groups; e.g., 3-[2-(2,4-Dichloro-phenyl)-ethoxy]-4-methoxy-N-[4-(pyrimidin-2-ylsulfamoyl)-phenyl]-benzamide; treating cardiovascular disorders such as thromboses and restenoses |
| 06/27/2006 | US7067660 Process for the preparation of pyrazolopyrimidinones |
| 06/27/2006 | US7067553 Thiourea compounds and the pharmaceutical compositions containing the same |
| 06/27/2006 | US7067543 Anthranilic acid amides and pharmaceutical use thereof |
| 06/27/2006 | US7067542 Diaminediols for the treatment of Alzheimer's disease |
| 06/27/2006 | US7067541 2-amino-pyridine derivatives useful for the treatment of diseases |
| 06/27/2006 | US7067540 Antiinflammatory agents; antiarthritic agents; antihistamines; sepsis shock; antidiabetic agents; bone disorders |
| 06/27/2006 | US7067539 Cannabinoid receptor ligands |
| 06/27/2006 | US7067538 monocyte chemoattractant protein-1; a bis(phenyl) sulfonyl or sulfonamido ketone or dihydroxy compound; antiinflammatory, anticholesterol, antiarthritic agents; immunotherapy; transplant rejection |
| 06/27/2006 | US7067517 Use of compounds for decreasing activity of hormone-sensitive lipase |
| 06/27/2006 | US7067516 Compounds used as antiinflammatory agents and enzyme inhibitors |
| 06/27/2006 | US7067506 Compounds useful for inhibiting Chk1 |
| 06/27/2006 | US7067119 Using polypeptides |
| 06/27/2006 | CA2238633C Alpha-substituted arylsulphonamido hydroxamic acids as tnf-alpha and matrix metalloproteinase inhibitors |
| 06/22/2006 | WO2006065946A1 Pyrid-2-ones useful as inhibitors of tec family protein kinases for the treatment of inflammatory, proliferative and immunologically-mediated diseases |
| 06/22/2006 | WO2006065706A1 N-biaryl and n-arylheteroaryl 2-substituted piperazine derivatives as modulators of the 5ht2c receptor useful for the treatment of disorders related thereto |
| 06/22/2006 | WO2006065600A2 N-biaryl and n-arylheteroaryl piperazine derivatives as modulators of the 5ht2c receptor useful for the treatment of disorders related thereto |
| 06/22/2006 | WO2006065590A2 Pyridine and pyrimidine antiviral compositions |
| 06/22/2006 | WO2006065204A1 Substituted aminopyridines and uses thereof |
| 06/22/2006 | WO2006064875A1 Novel bis(quaternary ammonium salt) compound with bactericidal activity |
| 06/22/2006 | WO2006063999A1 2-arylpropionic acid derivatives and pharmaceutical compositions containing them |
| 06/22/2006 | WO2006063801A1 Novel polymorph of (5-amino-6-methoxy-3-pyridincarbonyl)carbamic acid 2-(s)-hydroxymutilin 14-ester |
| 06/22/2006 | WO2006063718A1 Piperazinyl pyridine derivatives as anti-obesity agents |
| 06/22/2006 | WO2006063656A1 Method for producing onium salts comprising alkyl anions or aryl sulfonate anions or alkyl anions or aryl carboxylate anions having a low halide content |
| 06/22/2006 | WO2006063654A1 Method for producing onium alkyl sulfates with a low halogenide content |
| 06/22/2006 | WO2006063653A1 Method for the production of onium salts with tetrafluoroborate anion having a reduced halide content |
| 06/22/2006 | US20060135722 Substituted pyridyl amine catalysts and processes for polymerizing crystalline polymers |
| 06/22/2006 | US20060135577 EDG (Endothelial differentiation gene)-2 antagonist; chronic asthma, glomerular nephritis, obesity, prostate hyperplasia, arteriosclerosis, atopic dermatitis; (1) 3-(N-((2-(2-((4-chlorobenzylamino)carbonyl)phenyl)phenyl)carbonyl)-N-(2-(2-methoxyphenyl)ethyl)amino)propanoic acid |
| 06/22/2006 | US20060135568 Methods of treating microbial infections in humans and animals |
| 06/22/2006 | US20060135504 N-(substituted arylmethyl)-4-(disubstituted methyl) piperidines and pyridines |
| 06/22/2006 | US20060135480 Derivatives of succinic and glutaric acids and analogs thereof useful as inhibitors of phex |
| 06/22/2006 | US20060135367 2,5 -Difluoro-N-isobutyl-N-(8-propyl-[1,2,4]triazolo,[1,5-c]pyrimidin-7-ylmethyl)-benzamide; gamma aminobutyric acid receptor (GABAR) agonist/antagonist; anxiolitic, antidepressant; sleep disorder, attention deficit disorder, schizophrenia or Alzheimer's dementia |
| 06/22/2006 | US20060135352 Process for polymerizing olefins with non-metallocene catalysts |
| 06/22/2006 | US20060134724 Method and probe for identifying bacterial virulence modifying agents, agents thus identifed, and their use |
| 06/22/2006 | US20060134465 Organic light emitting devices having carrier blocking layers comprising metal complexes |
| 06/22/2006 | US20060134228 Medicine for prevention of and treatment for amyloidosis |
| 06/22/2006 | US20060131762 Method for metal-organic production of organic intermediate products by means of aryl lithium-bases |
| 06/22/2006 | CA2591413A1 Pyrid-2-ones useful as inhibitors of tec family protein kinases for the treatment of inflammatory, proliferative and immunologically-mediated diseases |
| 06/22/2006 | CA2591324A1 Methods for producing a hexadentate bimetallic complex |
| 06/22/2006 | CA2590780A1 Process for the preparation of onium salts with a tetrafluoroborate anion having a reduced halide content |
| 06/22/2006 | CA2590339A1 Piperazinyl pyridine derivatives as anti-obesity agents |
| 06/22/2006 | CA2589777A1 Compounds and compositions as modulators of steroidal receptors and calcium channel activities |
| 06/22/2006 | CA2589495A1 2-arylpropionic acid derivatives and pharmaceutical compositions containing them |
| 06/22/2006 | CA2588595A1 N-biaryl and n-arylheteroaryl piperazine derivatives as modulators of the 5ht2c receptor useful for the treatment of disorders related thereto |
| 06/22/2006 | CA2588567A1 N-biaryl and n-arylheteroaryl 2-substituted piperazine derivatives as modulators of the 5ht2c receptor useful for the treatment of disorders related thereto |
| 06/21/2006 | EP1672961A1 Compound, charge transport material and organic electroluminescent device |
| 06/21/2006 | EP1672653A2 Patterned photovoltaic cell |
| 06/21/2006 | EP1671952A1 Dissymmetrical diazo dyes and their use in hair colouring compositions |
| 06/21/2006 | EP1671951A1 Non symmetric 2-pyridinium diazo compounds with a cationic or non cationic linking group, compositions comprising them, a dying process and kit thereof |
| 06/21/2006 | EP1671950A1 Cinnamoyl derivatives and use thereof |
| 06/21/2006 | EP1671949A2 Substituted phenylamines and pyridinylamines |
| 06/21/2006 | EP1671948A1 Cinnamoyl compound and use of the same |
| 06/21/2006 | EP1670794A2 Vanilloid receptor ligands and their use in treatments |
| 06/21/2006 | EP1670783A2 Antithrombotic aromatic ethers |
| 06/21/2006 | EP1670775A1 Piperazine subtituted compounds used as calcium channel blockers |
| 06/21/2006 | EP1670772A1 Derivatives of 1,3-diones having a herbicidal activity |
| 06/21/2006 | EP1670764A1 Cyclohexene compounds |
| 06/21/2006 | EP1670763A1 Cyclopentene compounds |
| 06/21/2006 | EP1670762A1 Pyridylacetylenes for use as radiotracers and imaging agents |
| 06/21/2006 | EP1670756A1 Heterocyclyl compounds |
| 06/21/2006 | EP1670749A1 2-substituted benzoic acid derivatives as hm74a receptor agonists |
| 06/21/2006 | EP1670744A1 4-((phenoxyalkyl)thio)-phenoxyacetic aci ds and analogs |
| 06/21/2006 | EP1670743A1 Production process of optically pure 2-(4-hydroxyphenoxy)-propionic acid compounds |
| 06/21/2006 | EP1670742A1 Process for the preparation of roflumilast |
| 06/21/2006 | EP1670485A1 Treatment of diseases associated with the egr-1 enhancer element |
| 06/21/2006 | EP1556323A4 Metal chelates and methods of using them for time-resolved fluorescence |
| 06/21/2006 | EP1286985B1 Substituted pyridine herbicides |
| 06/21/2006 | EP1049662B1 Inhibitors of alpha4 mediated cell adhesion |
| 06/21/2006 | CN1791607A Chiral ligands and their transition metal complexes |
| 06/21/2006 | CN1791593A Pyridinyl carbamates |
| 06/21/2006 | CN1791580A Biaryl substituted 6-membered heterocyles as sodium channel blockers |
| 06/21/2006 | CN1791576A Benzamide modulators of metabotropic glutamate receptors |
| 06/21/2006 | CN1791572A Novel compounds |
| 06/21/2006 | CN1791568A Hsp90 family protein inhibitors |
| 06/21/2006 | CN1791409A (3-{3-' (2,4-bis- trifluormethyl -benzyl)-(5 -ethyl-pyrimidin -2-yl)- amino! -propoxy} -phenyl) -acetic acid and related compounds as modulators of ppars and methods of treating metabolic disorders |
| 06/21/2006 | CN1791407A [(2-hydroxy-2-(4-hydroxy-3-hydroxymethylphenyl)-ethylamino)-propyl] phenyl derivatives as beta2 agonists |
| 06/21/2006 | CN1789246A Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases |
| 06/20/2006 | US7064214 Reacting an amino-containing sulfinic acid with a metal hydrocarbon or halometal hydrocarbon to obtain a sterically pure product; pantoprazole; omeproazole; lansproazole; rabeproazoe; gastrointestinal disorders |